5-ht2 (bovine)

Loxapine succinate (Loxapac), a D2DR and D4DR inhibitor, is utilized in schizophrenia.

5-Benzyloxytryptamine (5-BT) is a selective partial agonist of the 5-hydroxytryptamine 1D/1B (5-HT1D/1B) receptors, with an IC50 value of 40 nM for the bovine caudate nucleus 5-HT1D. It exhibits much lower affinity for other receptors (5-HT2 IC50 > 470 nM). 5-Benzyloxytryptamine inhibits adenylate cyclase, leading to reduced neurotransmitter release and downregulation of cAMP signaling. It holds potential for research into diseases associated with neurotransmitter imbalances.

Loxapine is a D2DR and D4DR inhibitor, serotonergic receptor antagonist and also a dibenzoxazepine anti-psychotic agent,used primarily in the treatment of schizophrenia. The drug is a member of the dibenzoxazepine class and structurally related to clozapine (which belongs to the chemically akin class of dibenzodiazepines).